Recently, Cytotoxic T lymphocyte-associated antigen-4 (CTLA-4) gene has emerged as an attractive candidate gene implicated in susceptibility to autoimmune disease such as Juvenile-onset SLE (JSLE).
Objective
To investigate CTLA-4 exon 1 + 49A/G (rs231775) SNP as a genetic marker for susceptibility to JSLE and lupus nephritis in Egyptian children and adolescents.
Methods
This prospective case-control study included 260 patients diagnosed with Juvenile-onset SLE, and 260 healthy controls. We genotyped all participants for CTLA-4 (A/G) (rs231775) SNP located in exon 1 at position 49 by polymerase chain reaction.
Results
The CTLA-4 exon 1 + 49G/G gene variant and G allele were significantly more represented in JSLE patients than healthy controls (27% vs 8%; ORs = 4.2; [95% CI: 2.4 – 7.3]; for the G/G genotype) and (47.5% vs 35%; ORs: 1.7; [95% CIs: 1.3 – 2.2]; for G allele); P < .01. The CTLA-4 G/G genotype and G allele were identified as possible risk factors for development of lupus nephritis (for G/G genotype; ORs: 5.09; [95% CIs: 1.7 - 13.9]; P = .0001, and for G-allele; ORs: 2.4; [95% CIs: 1.5 - 3.78]; P = .004).
Conclusion
The CTLA-4 exon 1 + 49A/G polymorphism may confer susceptibility to Juvenile-onset SLE. Moreover, CTLA-4 G/G genotype and G allele at exon 1 + 49 may constitute independent risk factors for development of lupus nephritis in Egyptian children and adolescents.
SmithEMDLythgoeHMidgleyA, et al.Juvenile-onset systemic lupus erythematosus: update on clinical presentation, pathophysiology and treatment options. Clin Immunol2019; 209: 108274.
2.
TsokosGC. Systemic lupus erythematosus. N Engl J Med2011; 365: 2110–2121.
3.
SatoVAMarquesIDGoldensteinPT, et al.Lupus nephritis is more severe in children and adolescents than in older adults. Lupus2012; 21(9): 978–983.
4.
TarrTDérfalviBGyőriN, et al.Similarities and differences between pediatric and adult patients with systemic lupus erythematosus. Lupus2015; 24(8): 796–803.
5.
ChoiJKimSTCraftJ. The pathogenesis of systemic lupus erythematosus-an update. Curr Opin Immunol2012; 24(6): 651–657.
6.
MoultonVRTsokosGC. Abnormalities of T cell signaling in systemic lupus erythematosus. Arthritis Res Ther2011; 13(2): 207.
7.
SansomDM. CD28, CTLA-4 and their ligands: who does what and to whom?Immunology2000; 101(2): 169–177.
8.
KosmaczewskaACiszakLBoćkoD, et al.Expression and functional significance of CTLA-4, a negative regulator of T cell activation. Arch Immunol Ther Exp2001; 49(1): 39–46.
9.
BrunnerMCChambersCAChanFK, et al.CTLA-4-Mediated inhibition of early events of T cell proliferation. J Immunol1999; 162(10): 5813–5820.
10.
FinckBKLinsleyPSWofsyD. Treatment of Murine lupus with CTLA4Ig. Science1994; 265(5176): 1225–1227.
11.
HarperKBalzanoCRouvierE, et al.CTLA-4 and CD28 activated lymphocyte molecules are closely related in both mouse and human as to sequence, message expression, gene structure, and chromosomal location. J Immunol1991; 147(3): 1037–1044.
12.
KoukiTSawaiYGardineCA, et al.CTLA-4 gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of graves' disease. J Immunol2000; 165(11): 6606–6611.
13.
LeeYHHarleyJBNathSK. CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): a meta-analysis. Hum Genet2005; 116(5): 361–367.
14.
SugimotoKFujitaSYanagidaH, et al.Clinical manifestations and analyses of the cytotoxic T-lymphocyte associated-4 gene in two Japanese families with systemic lupus erythematosus. Clin Exp Nephrol2008; 12(2): 149–154.
15.
HochbergMC. Updating the American college of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum1997; 40(9): 1725.
HammarénRGoldsteinSTSchlebuschCM. Eurasian back-migration into Northeast Africa was a complex and multifaceted process. PLoS One2023; 18(11): e0290423.
18.
WeeningJJD'AgatiVDSchwartzMM, et al.The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol2004; 15(2): 241–250.
19.
KatkamSKKumaraswamiKRupasreeY, et al.Association of CTLA4 exon-1 polymorphism with the tumor necrosis factor-α in the risk of systemic lupus erythematosus among South Indians. Hum Immunol2016; 77(2): 158–164.
20.
KristiansenOPLarsenZMPociotF. CTLA-4 in autoimmune diseases--a general susceptibility gene to autoimmunity?Gene Immun2000; 1(3): 170–184.
21.
LeeYHHarleyJBNathSK. CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): a meta-analysis. Hum Genet2005; 116(5): 361–367.
22.
ZhaiJXZouLWZhangZX, et al.CTLA-4 polymorphisms and systemic lupus erythematosus (SLE): a meta-analysis. Mol Biol Rep2013; 40(9): 5213–5223.
23.
UlkerMYazisizVSallakciN, et al.CTLA-4 gene polymorphism of exon 1(+49 A/G) in Turkish systemic lupus erythematosus patients. Int J Immunogenet2009; 36(4): 245–250.
24.
PullmannRJLukácJSkerenováM, et al.Cytotoxic T lymphocyte antigen 4 (CTLA-4) dimorphism in patients with systemic lupus erythematosus. Clin Exp Rheumatol1999; 17(6): 725–729.
25.
KatkamSKKumaraswamiKRupasreeY, et al.Association of CTLA4 exon-1 polymorphism with the tumor necrosis factor-α in the risk of systemic lupus erythematosus among South Indians. Hum Immunol2016; 77(2): 158–164.
26.
DevarajuPGulatiRSinghBK, et al.The CTLA4 +49 A/G (rs231775) polymorphism influences susceptibility to SLE in south Indian tamils. Tissue Antigens2014; 83(6): 418–421.
27.
HewardJGordonCAllahabadiaA, et al.The A-G polymorphism in exon 1 of the CTLA-4 gene is not associated with systemic lupus erythematosus. Ann Rheum Dis1999; 58(3): 193–195.
28.
AguilarFTorresBSánchez-RománJ, et al.CTLA4 polymorphism in Spanish patients with systemic lupus erythematosus. Hum Immunol2003; 64(10): 936–940.
29.
LiuMFWangCRLinLC, et al.CTLA-4 gene polymorphism in promoter and exon-1 regions in Chinese patients with systemic lupus erythematosus. Lupus2001; 10(9): 647–649.
30.
ChuaKHPuahSMChewCH, et al.Study of the CTLA-4 gene polymorphisms in systemic lupus erythematosus (SLE) samples from Malaysia. Ann Hum Biol2010; 37(2): 274–280.
31.
LeeYHKimYRJiJD, et al.Polymorphisms of the CTLA-4 exon 1 and promoter gene in systemic lupus erythematosus. Lupus2001; 10(9): 601–605.
32.
WangJJShiYPYueH, et al.CTLA-4 exon 1 +49A/G polymorphism is associated with renal involvement in pediatric Henoch-Schönlein purpura. Pediatr Nephrol2012; 27(11): 2059–2064.
33.
StohlWJacobNQuinnWJ3rd, et al.Global T cell dysregulation in non-autoimmune-prone mice promotes rapid development of BAFF-independent, systemic lupus erythematosus-like autoimmunity. J Immunol2008; 181(1): 833–841.
34.
VaidyaBPearceSHCharltonS, et al.An association between the CTLA4 exon 1 polymorphism and early rheumatoid arthritis with autoimmune endocrinopathies. Rheumatology2002; 41(2): 180–183.
35.
ThompsonCBAllisonJP. The emerging role of CTLA-4 as an immune attenuator. Immunity1997; 7(4): 445–450.
36.
ChenL. Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat Rev Immunol2004; 4(5): 336–347.
37.
BarretoMSantosEFerreiraR, et al.Evidence for CTLA4 as a susceptibility gene for systemic lupus erythematosus. Eur J Hum Genet2004; 12(8): 620–626.
38.
FraserJHRincónMMcCoyKD, et al.CTLA4 ligation attenuates AP-1, NFAT and NF-kappaB activity in activated T cells. Eur J Immunol1999; 29(3): 838–844.
39.
MartinsGATadokoroCESilvaRB, et al.CTLA-4 blockage increases resistance to infection with the intracellular protozoan Trypanosoma cruzi. J Immunol2004; 172(8): 4893–4901.
40.
KailashiyaVSharmaHBKailashiyaJ. Role of CTLA4 A49G polymorphism in systemic lupus erythematosus and its geographical distribution. J Clin Pathol2019; 72(10): 659–662.
41.
MäurerMLoserthSKolb-MäurerA, et al.A polymorphism in the human cytotoxic T-lymphocyte antigen 4 (CTLA4) gene (Exon 1 +49) alters T-cell activation. Immunogenetics2002; 54(1): 1–8.
42.
TomerYGreenbergDABarbesinoG, et al.CTLA-4 and not CD28 is a susceptibility gene for thyroid autoantibody production. J Clin Endocrinol Metab2001; 86(4): 1687–1693.
43.
AnjosSNguyenAOunissi-BenkalhaH, et al.A common autoimmunity predisposing signal peptide variant of the cytotoxic T-lymphocyte antigen 4 results in inefficient glycosylation of the susceptibility allele. J Biol Chem2002; 277(48): 46478–46486.
44.
OaksMKHallettKM. Cutting edge: a soluble form of CTLA-4 in patients with autoimmune thyroid disease. J Immunol2000; 164(10): 5015–5018.
45.
SimoneRPesceGAntolaP, et al.The soluble form of CTLA-4 from serum of patients with autoimmune diseases regulates T-cell responses. BioMed Res Int2014; 2014: 215763.
46.
WongCKLitLCTamLS, et al.Aberrant production of soluble costimulatory molecules CTLA-4, CD28, CD80 and CD86 in patients with systemic lupus erythematosus. Rheumatology2005; 44(8): 989–994.
47.
MarronMPZeidlerARaffelLJ, et al.Genetic and physical mapping of a type 1 diabetes susceptibility gene (IDDM12) to a 100-kb phagemid artificial chromosome clone containing D2S72-CTLA4-D2S105 on chromosome 2q33. Diabetes2000; 49(3): 492–499.
48.
ChokkalingamAPAldrichMCBartleyK, et al.Matching on race and ethnicity in case-control studies as a means of control for population stratification. Epidemiology2011; 1: 101.
49.
WangHHaimanCAKolonelLN, et al.Self-reported ethnicity, genetic structure and the impact of population stratification in a multiethnic study. Hum Genet2010; 128(2): 165–177.
50.
LeeYLTeitelbaumSWolffMS, et al.Comparing genetic ancestry and self-reported race/ethnicity in a multiethnic population in New York city. J Genet2010; 89(4): 417–423.
51.
GouveiaMHBentleyARLealTP, et al.Unappreciated subcontinental admixture in Europeans and european Americans and implications for genetic epidemiology studies. Nat Commun2023; 14(1): 6802.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
